Ultra-long-acting removable drug delivery system for HIV treatment and prevention
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ultra-long-acting removable drug delivery system for HIV treatment and prevention
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-02
DOI
10.1038/s41467-018-06490-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Creation of a long-acting nanoformulated dolutegravir
- (2018) Brady Sillman et al. Nature Communications
- Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity
- (2016) Kaitlin Anstett et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges
- (2016) Martina Kovarova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions
- (2016) Rikke Olesen et al. JOURNAL OF CLINICAL INVESTIGATION
- Review of Pharmaceutical Applications of N-Methyl-2-Pyrrolidone
- (2016) Abolghasem Jouyban et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection
- (2015) Olivia D. Council et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge
- (2015) J. Radzio et al. Science Translational Medicine
- Long-acting rilpivirine for HIV prevention
- (2015) Akil Jackson et al. Current Opinion in HIV and AIDS
- Formulation and pharmacology of long-acting cabotegravir
- (2015) Christine Trezza et al. Current Opinion in HIV and AIDS
- Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission
- (2015) Martina Kovarova et al. PLoS Pathogens
- High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort Substudy
- (2014) Kathrine Meyers et al. PLoS One
- Refilling drug delivery depots through the blood
- (2014) Y. Brudno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV negative women
- (2013) Jessica L Adams et al. ANTIVIRAL THERAPY
- Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir
- (2013) Mackenzie L. Cottrell et al. CLINICAL PHARMACOKINETICS
- Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
- (2013) Kachit Choopanya et al. LANCET
- Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
- (2013) Sallie R Permar et al. Retrovirology
- Effectiveness of Long-Acting Reversible Contraception
- (2012) Brooke Winner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
- (2012) Michael C. Thigpen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Breast Milk and Antiretrovirals Dramatically Reduce Oral HIV-1 Transmission in BLT Humanized Mice
- (2012) Angela Wahl et al. PLoS Pathogens
- Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection
- (2011) Rikke Olesen et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
- (2011) P. W. Denton et al. JOURNAL OF VIROLOGY
- Generation of HIV Latency in Humanized BLT Mice
- (2011) P. W. Denton et al. JOURNAL OF VIROLOGY
- Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages
- (2011) C. Ochsenbauer et al. JOURNAL OF VIROLOGY
- Marginal association measures for clustered data
- (2011) Douglas J. Lorenz et al. STATISTICS IN MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
- (2009) Jesus F. Salazar-Gonzalez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice
- (2008) Paul W Denton et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started